Observational studyBlood cancer journal2023

Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy.

Christopher J Ferreri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.